Top compounds associated with response to TMPO


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.07
mRNA vorapaxar CTRPv2 pan-cancer AAC 0.043 0.3
mRNA vincristine CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.077 0.04
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.04 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.11 0.03
mRNA triptolide CTRPv2 pan-cancer AAC 0.034 0.4
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.077 0.06
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.15 3e-06
Download CSV